Latest Capital Raise News

Pacific Edge Limited has opened a $5 million Share Purchase Plan at $0.10 per share, conditional on shareholder approval of a prior $16.1 million Placement. The capital raise aims to extend the company’s cash runway and accelerate US market adoption of its bladder cancer diagnostic tests amid Medicare non-coverage.

Visionflex Group Limited reported a positive operating cash flow for the June 2025 quarter alongside revised convertible note facilities with key investors, signaling steady liquidity and funding stability.

Rox Resources has made significant strides in advancing its Youanmi Gold Project, backed by a $40 million capital raise and promising drilling results that underpin an imminent resource update and feasibility study.

Pacific Edge Limited (ASX – PEB) has announced a securities purchase plan (SPP) aiming to raise up to NZD 5 million, contingent on shareholder approval of a prior NZD 16 million placement. The move is designed to bolster working capital amid ongoing growth initiatives.

Dreadnought Resources Limited reported a solid cash flow quarter ending June 2025, with a net cash increase of AUD 3.1 million and a funding runway extending to five quarters. The company’s financial position reflects strategic financing activity amid ongoing exploration investments.

Dreadnought Resources has fortified its balance sheet with an $8.5 million capital raise and secured a $15 million joint venture with Teck Resources, advancing its Mangaroon gold and critical minerals projects.

Complii FinTech Solutions reported an 11.8% increase in customer receipts for Q4 FY25, alongside a 4.3% quarterly rise in annual recurring revenue, underscoring its expanding footprint in capital raising and compliance software.

betr Entertainment Limited has launched an all-scrip takeover bid for PointsBet Holdings Limited, offering 3.81 betr shares for every PointsBet share, valuing PointsBet at $1.22 per share and promising significant cost synergies.

Kula Gold Limited has reported impressive high-grade gold drilling results at its Mt Palmer Gold Mine, completing an 80% JV earn-in, while progressing exploration at Kirup and securing a niobium project approval in Malawi. The company faces a tight cash position but is actively managing funding.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.

Imugene Limited has launched a A$37.5 million capital raising to advance its promising off-the-shelf CAR T therapy, azer-cel, following encouraging Phase 1b data showing a 75% overall response rate in lymphoma patients.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.